HEADER TRANSFERASE 01-DEC-18 6IBZ
TITLE HUMAN PFKFB3 IN COMPLEX WITH A N-ARYL 6-AMINOQUINOXALINE INHIBITOR 7
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: PFK/FBPASE 3,6PF-2-K/FRU-2,6-P2ASE BRAIN/PLACENTA-TYPE
COMPND 5 ISOZYME,RENAL CARCINOMA ANTIGEN NY-REN-56,IPFK-2;
COMPND 6 EC: 2.7.1.105,3.1.3.46;
COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: PFKFB3;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS CANCER, METABOLISM, KINASE, INHIBITOR, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR K.BANASZAK,M.TOMCZYK,P.GUZIK,C.H.FABRITIUS,M.NOWAK
REVDAT 4 24-JAN-24 6IBZ 1 HETSYN
REVDAT 3 29-JUL-20 6IBZ 1 COMPND REMARK HETNAM SITE
REVDAT 2 13-FEB-19 6IBZ 1 JRNL
REVDAT 1 23-JAN-19 6IBZ 0
JRNL AUTH N.BOUTARD,A.BIALAS,A.SABINIARZ,P.GUZIK,K.BANASZAK,A.BIELA,
JRNL AUTH 2 M.BIEN,A.BUDA,B.BUGAJ,E.CIELUCH,A.CIERPICH,L.DUDEK,
JRNL AUTH 3 H.M.EGGENWEILER,J.FOGT,M.GAIK,A.GONDELA,K.JAKUBIEC,M.JURZAK,
JRNL AUTH 4 A.KITLINSKA,P.KOWALCZYK,M.KUJAWA,K.KWIECINSKA,M.LES,
JRNL AUTH 5 R.LINDEMANN,M.MACIUSZEK,M.MIKULSKI,P.NIEDZIEJKO,A.OBARA,
JRNL AUTH 6 H.PAWLIK,T.RZYMSKI,M.SIEPRAWSKA-LUPA,M.SOWINSKA,
JRNL AUTH 7 J.SZEREMETA-SPISAK,A.STACHOWICZ,M.M.TOMCZYK,K.WIKLIK,
JRNL AUTH 8 L.WLOSZCZAK,S.ZIEMIANSKA,A.ZAREBSKI,K.BRZOZKA,M.NOWAK,
JRNL AUTH 9 C.H.FABRITIUS
JRNL TITL SYNTHESIS OF AMIDE AND SULFONAMIDE SUBSTITUTED N-ARYL
JRNL TITL 2 6-AMINOQUINOXALINES AS PFKFB3 INHIBITORS WITH IMPROVED
JRNL TITL 3 PHYSICOCHEMICAL PROPERTIES.
JRNL REF BIOORG. MED. CHEM. LETT. V. 29 646 2019
JRNL REFN ESSN 1464-3405
JRNL PMID 30626557
JRNL DOI 10.1016/J.BMCL.2018.12.034
REMARK 2
REMARK 2 RESOLUTION. 2.44 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.44
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.74
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9
REMARK 3 NUMBER OF REFLECTIONS : 29337
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.194
REMARK 3 R VALUE (WORKING SET) : 0.192
REMARK 3 FREE R VALUE : 0.234
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000
REMARK 3 FREE R VALUE TEST SET COUNT : 1223
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3510
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 72
REMARK 3 SOLVENT ATOMS : 126
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 44.58
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.09
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -0.25000
REMARK 3 B22 (A**2) : -0.25000
REMARK 3 B33 (A**2) : 0.82000
REMARK 3 B12 (A**2) : -0.13000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.241
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.206
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.156
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.086
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA
REMARK 3 BOND LENGTH (A) : NULL ; NULL
REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL
REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL
REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL
REMARK 3
REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL
REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL
REMARK 3
REMARK 3 NON-BONDED CONTACT RESTRAINTS.
REMARK 3 SINGLE TORSION (A) : NULL ; NULL
REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL
REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL
REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL
REMARK 3
REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS.
REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL
REMARK 3 PLANAR (DEGREES) : NULL ; NULL
REMARK 3 STAGGERED (DEGREES) : NULL ; NULL
REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 6IBZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-DEC-18.
REMARK 100 THE DEPOSITION ID IS D_1200013067.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 06-JUL-15
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : BESSY
REMARK 200 BEAMLINE : 14.1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : XSCALE
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30561
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.440
REMARK 200 RESOLUTION RANGE LOW (A) : 47.740
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9
REMARK 200 DATA REDUNDANCY : 10.68
REMARK 200 R MERGE (I) : 0.15300
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.8400
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.44
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59
REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5
REMARK 200 DATA REDUNDANCY IN SHELL : 10.81
REMARK 200 R MERGE FOR SHELL (I) : 0.92800
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.590
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 3QPU
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 68.31
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.88
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 2% TACSIMATE, PH7.0; 5% 2-PROPANOL;
REMARK 280 0.1M IMIDAZOLE; 8% PEG3350, VAPOR DIFFUSION, SITTING DROP,
REMARK 280 TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 2 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -Y,X-Y,Z+2/3
REMARK 290 3555 -X+Y,-X,Z+1/3
REMARK 290 4555 -X,-Y,Z+1/2
REMARK 290 5555 Y,-X+Y,Z+1/6
REMARK 290 6555 X-Y,X,Z+5/6
REMARK 290 7555 Y,X,-Z+2/3
REMARK 290 8555 X-Y,-Y,-Z
REMARK 290 9555 -X,-X+Y,-Z+1/3
REMARK 290 10555 -Y,-X,-Z+1/6
REMARK 290 11555 -X+Y,Y,-Z+1/2
REMARK 290 12555 X,X-Y,-Z+5/6
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 169.29200
REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 84.64600
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 126.96900
REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 42.32300
REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 211.61500
REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 169.29200
REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 84.64600
REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 42.32300
REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 126.96900
REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 211.61500
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 1230 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 20430 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 LYS A 204 CG CD CE NZ
REMARK 470 GLU A 342 CG CD OE1 OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 ARG A 378 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 GLN A 80 137.59 -32.75
REMARK 500 ASN A 127 46.15 38.24
REMARK 500 LYS A 204 -90.51 -139.08
REMARK 500 ASP A 267 48.42 -142.49
REMARK 500 GLU A 330 -3.99 79.67
REMARK 500 ASP A 350 70.69 -161.10
REMARK 500 GLU A 380 -103.10 -98.47
REMARK 500 CYS A 386 -139.49 -144.27
REMARK 500 ALA A 423 92.03 50.37
REMARK 500 TYR A 424 -19.45 81.96
REMARK 500
REMARK 500 REMARK: NULL
DBREF 6IBZ A 3 446 UNP Q16875 F263_HUMAN 4 447
SEQADV 6IBZ A UNP Q16875 ARG 20 DELETION
SEQADV 6IBZ A UNP Q16875 PRO 21 DELETION
SEQADV 6IBZ A UNP Q16875 SER 22 DELETION
SEQADV 6IBZ A UNP Q16875 LEU 23 DELETION
SEQADV 6IBZ A UNP Q16875 PRO 24 DELETION
SEQADV 6IBZ A UNP Q16875 ARG 25 DELETION
SEQADV 6IBZ A UNP Q16875 SER 26 DELETION
SEQADV 6IBZ A UNP Q16875 CYS 27 DELETION
SEQADV 6IBZ A UNP Q16875 GLY 28 DELETION
SEQADV 6IBZ A UNP Q16875 PRO 29 DELETION
SEQADV 6IBZ A UNP Q16875 LYS 30 DELETION
SEQADV 6IBZ A UNP Q16875 LEU 31 DELETION
SEQADV 6IBZ A UNP Q16875 THR 32 DELETION
SEQRES 1 A 431 GLU LEU THR GLN SER ARG VAL GLN LYS ILE TRP VAL PRO
SEQRES 2 A 431 VAL ASP HIS ASN SER PRO THR VAL ILE VAL MET VAL GLY
SEQRES 3 A 431 LEU PRO ALA ARG GLY LYS THR TYR ILE SER LYS LYS LEU
SEQRES 4 A 431 THR ARG TYR LEU ASN TRP ILE GLY VAL PRO THR LYS VAL
SEQRES 5 A 431 PHE ASN VAL GLY GLU TYR ARG ARG GLU ALA VAL LYS GLN
SEQRES 6 A 431 TYR SER SER TYR ASN PHE PHE ARG PRO ASP ASN GLU GLU
SEQRES 7 A 431 ALA MET LYS VAL ARG LYS GLN CYS ALA LEU ALA ALA LEU
SEQRES 8 A 431 ARG ASP VAL LYS SER TYR LEU ALA LYS GLU GLY GLY GLN
SEQRES 9 A 431 ILE ALA VAL PHE ASP ALA THR ASN THR THR ARG GLU ARG
SEQRES 10 A 431 ARG HIS MET ILE LEU HIS PHE ALA LYS GLU ASN ASP PHE
SEQRES 11 A 431 LYS ALA PHE PHE ILE GLU SER VAL CYS ASP ASP PRO THR
SEQRES 12 A 431 VAL VAL ALA SER ASN ILE MET GLU VAL LYS ILE SER SER
SEQRES 13 A 431 PRO ASP TYR LYS ASP CYS ASN SER ALA GLU ALA MET ASP
SEQRES 14 A 431 ASP PHE MET LYS ARG ILE SER CYS TYR GLU ALA SER TYR
SEQRES 15 A 431 GLN PRO LEU ASP PRO ASP LYS CYS ASP ARG ASP LEU SER
SEQRES 16 A 431 LEU ILE LYS VAL ILE ASP VAL GLY ARG ARG PHE LEU VAL
SEQRES 17 A 431 ASN ARG VAL GLN ASP HIS ILE GLN SER ARG ILE VAL TYR
SEQRES 18 A 431 TYR LEU MET ASN ILE HIS VAL GLN PRO ARG THR ILE TYR
SEQRES 19 A 431 LEU CYS ARG HIS GLY GLU ASN GLU HIS ASN LEU GLN GLY
SEQRES 20 A 431 ARG ILE GLY GLY ASP SER GLY LEU SER SER ARG GLY LYS
SEQRES 21 A 431 LYS PHE ALA SER ALA LEU SER LYS PHE VAL GLU GLU GLN
SEQRES 22 A 431 ASN LEU LYS ASP LEU ARG VAL TRP THR SER GLN LEU LYS
SEQRES 23 A 431 SER THR ILE GLN THR ALA GLU ALA LEU ARG LEU PRO TYR
SEQRES 24 A 431 GLU GLN TRP LYS ALA LEU ASN GLU ILE ASP ALA GLY VAL
SEQRES 25 A 431 CYS GLU GLU LEU THR TYR GLU GLU ILE ARG ASP THR TYR
SEQRES 26 A 431 PRO GLU GLU TYR ALA LEU ARG GLU GLN ASP LYS TYR TYR
SEQRES 27 A 431 TYR ARG TYR PRO THR GLY GLU SER TYR GLN ASP LEU VAL
SEQRES 28 A 431 GLN ARG LEU GLU PRO VAL ILE MET GLU LEU GLU ARG GLN
SEQRES 29 A 431 GLU ASN VAL LEU VAL ILE CYS HIS GLN ALA VAL LEU ARG
SEQRES 30 A 431 CYS LEU LEU ALA TYR PHE LEU ASP LYS SER ALA GLU GLU
SEQRES 31 A 431 MET PRO TYR LEU LYS CYS PRO LEU HIS THR VAL LEU LYS
SEQRES 32 A 431 LEU THR PRO VAL ALA TYR GLY CYS ARG VAL GLU SER ILE
SEQRES 33 A 431 TYR LEU ASN VAL GLU SER VAL CYS THR HIS ARG GLU ARG
SEQRES 34 A 431 SER GLU
HET PO4 A 501 5
HET FLC A 502 13
HET HAW A 503 38
HET F6P A 504 16
HETNAM PO4 PHOSPHATE ION
HETNAM FLC CITRATE ANION
HETNAM HAW 2-[[8-(1-METHYLINDOL-6-YL)QUINOXALIN-6-YL]AMINO]-~{N}-
HETNAM 2 HAW (PYRIMIDIN-5-YLMETHYL)BENZENESULFONAMIDE
HETNAM F6P 6-O-PHOSPHONO-BETA-D-FRUCTOFURANOSE
HETSYN F6P FRUCTOSE-6-PHOSPHATE; 6-O-PHOSPHONO-BETA-D-FRUCTOSE; 6-
HETSYN 2 F6P O-PHOSPHONO-D-FRUCTOSE; 6-O-PHOSPHONO-FRUCTOSE
FORMUL 2 PO4 O4 P 3-
FORMUL 3 FLC C6 H5 O7 3-
FORMUL 4 HAW C28 H23 N7 O2 S
FORMUL 5 F6P C6 H13 O9 P
FORMUL 6 HOH *126(H2 O)
HELIX 1 AA1 GLY A 46 ILE A 61 1 16
HELIX 2 AA2 VAL A 70 VAL A 78 1 9
HELIX 3 AA3 SER A 83 ARG A 88 5 6
HELIX 4 AA4 ASN A 91 GLU A 116 1 26
HELIX 5 AA5 THR A 129 GLU A 142 1 14
HELIX 6 AA6 ASP A 156 LYS A 168 1 13
HELIX 7 AA7 SER A 171 LYS A 175 5 5
HELIX 8 AA8 ASN A 178 ALA A 195 1 18
HELIX 9 AA9 ASP A 228 MET A 239 1 12
HELIX 10 AB1 ASN A 256 GLY A 262 1 7
HELIX 11 AB2 SER A 271 ASN A 289 1 19
HELIX 12 AB3 LEU A 300 ALA A 309 1 10
HELIX 13 AB4 LYS A 318 ASN A 321 5 4
HELIX 14 AB5 ALA A 325 GLU A 329 5 5
HELIX 15 AB6 THR A 332 TYR A 340 1 9
HELIX 16 AB7 TYR A 340 ASP A 350 1 11
HELIX 17 AB8 SER A 361 GLN A 379 1 19
HELIX 18 AB9 HIS A 387 LEU A 399 1 13
HELIX 19 AC1 GLU A 405 LEU A 409 5 5
SHEET 1 AA1 2 LEU A 4 GLN A 6 0
SHEET 2 AA1 2 TRP A 13 PRO A 15 -1 O VAL A 14 N THR A 5
SHEET 1 AA2 6 THR A 65 ASN A 69 0
SHEET 2 AA2 6 ILE A 120 ASP A 124 1 O VAL A 122 N PHE A 68
SHEET 3 AA2 6 THR A 35 VAL A 40 1 N ILE A 37 O PHE A 123
SHEET 4 AA2 6 LYS A 146 VAL A 153 1 O LYS A 146 N VAL A 36
SHEET 5 AA2 6 SER A 210 ILE A 215 1 O VAL A 214 N GLU A 151
SHEET 6 AA2 6 ARG A 220 ASN A 224 -1 O ARG A 220 N ILE A 215
SHEET 1 AA3 6 GLU A 315 GLN A 316 0
SHEET 2 AA3 6 ARG A 294 THR A 297 1 N VAL A 295 O GLU A 315
SHEET 3 AA3 6 VAL A 382 CYS A 386 1 O LEU A 383 N ARG A 294
SHEET 4 AA3 6 ILE A 248 ARG A 252 1 N TYR A 249 O VAL A 382
SHEET 5 AA3 6 THR A 415 VAL A 422 -1 O LEU A 419 N ILE A 248
SHEET 6 AA3 6 GLY A 425 TYR A 432 -1 O GLU A 429 N LYS A 418
CRYST1 103.046 103.046 253.938 90.00 90.00 120.00 P 65 2 2 12
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.009704 0.005603 0.000000 0.00000
SCALE2 0.000000 0.011206 0.000000 0.00000
SCALE3 0.000000 0.000000 0.003938 0.00000